* If you want to update the article please login/register
People living with HIV have elevated risks of tobacco use. This research was designed to determine the possibility of NVPs for promoting tobacco use among PLHIVs. By 35% of participants at Week 12 and 31% reported short-term abstinence at Week 24, the highest rate of abstinence was obtained. NVPs may be a simple and potentially beneficial short-to-medium term tobacco cessation aid and/or harm reduction tactic among PLHIV.
Source link: https://doi.org/10.1007/s10461-022-03797-0
Background Note: Despite the decline in cigarette use in the last two decades, tobacco use in the German adult population is still prevalent, accounting for 125,000 deaths each year and raising significant social costs. Evidence-based smoking cessation techniques are pivotal to a national tobacco control initiative, helping reduce the prevalence of tobacco use. The present research investigates the effectiveness of the national German Smokers Quitline, which offers cessation assistance to smokers. During an intervention period of about six weeks, participants will receive up to six proactive phone calls during the intervention period. Substance use management will be able to treat drug use both motivational interviewing and those of the cognitive behavioral approach. After three and a month of smoking cessation, it is predicted that in the telephone counseling condition, the nicotine cessation rates will be higher than in the control condition.
Source link: https://doi.org/10.1186/s12889-022-13742-4
Background Cigarette cessation has been dubbed the world's most significant public health intervention. The four-week follow-up data shows that for every twenty people given an e-cigarette, six quit smoking tobacco, and three people reduced their cigarette intake by more than five cigarettes per day. Conclusions E-cigarette packaging, as well as pharmacy support, appears to be an affordable and efficient method for smoking cessation, but more research is needed on long-term quit rates and health effects.
Source link: https://doi.org/10.1186/s12889-022-13711-x
Children and young people are in danger from tobacco smoke inhaled. To help them quit smoking, we gave 102 participants smoking cessation tips, including motivational interviewing and exhaled carbon monoxide measurements. Conclusion : Formal testing procedures on smoking and the offering of smoke cessation information should be a regular part of all respiratory clinics where CYP and parentage are seen. u2022 Adolescents with chronic respiratory problems may smoke or have parents who have one. u2022 Simple smoke cessation products can encourage young people and their parents to avoid smoking or reduce smoking.
Source link: https://doi.org/10.1007/s00431-022-04453-4
Objects: To look into the correlation between cumulative smoking exposure and span since smoking cessation has been linked to peri-implantitis. Methods The research involved a group of 350 people aged u2265-35 years, with the presence of at least one osseointegrated implant operating for more than five years, was included in the study. Participants were divided into three groups, non-smokers, former smokers, and current smokers based on their smoking habits. When compared to the FS and NS groups, a high prevalence of periodontitis was seen in the CS group.
Source link: https://doi.org/10.1007/s00784-022-04451-8
Objectives The aim of the study was to determine the effects of oral, oropharyngeal, laryngeal, and cancer disease, as well as cancer prevention in patients. Nicotine Dependence Patients 50 smoking patients were given a questionnaire of planned support, Schneider motivation test, and the Fagerstru00f6M Test for Nicotine Dependence. Results Meant Mean FTND score was 4. 58 and Heaviness of Smoking Index was 3. 1. Patients with oral cavity and oropharyngeal cancer had the highest dependence to nicotine 7. 67 and 5. 25, respectively, and hypopharyngeal cancer had the lowest 3. 5 percent. 76% reported a self-reported compulsion to quit smoking cessation.
Source link: https://doi.org/10.1007/s00405-021-07209-2
Background Currently community pharmacies provide people with high risks of tobacco-related disease, but pharmacy technicians are still low, with no throughput in NHS Stop Smoking Services in pharmacies. With environmental influences, the intervention was based on theory-based consultation skills training for pharmacists with environmental prompteds. In comparison to 641 in standard practice pharmacies, 631 adult smokers registered and set a quit date in intervention pharmacies, a rate ratio of 0. 5 adjusted for location and number of prescriptions. At 4 weeks in intervention and 276 in traditional practice pharmacies, a total of 265 service users quit smoking. All common practice arm service users, as well as one in the intervention arm, will recommend the service to smokers, with one exception. Conclusions We found high retention and acceptable quit rates in the NHS pharmacy stop smoking program.
Source link: https://doi.org/10.1186/s12916-022-02412-2
Purpose: Smoking cessation in patients with diagnosed lung cancer has improved outcomes on cancer therapy and overall prognosis. Despite this, lung cancer patients' information on smoking cessation is slim. Following a confirmed lung cancer diagnosis, responsive patients were enrolled. Based on biochemical analysis, the primary endpoint was the point prevalence abstinence rate at week 12 (based on biochemical evidence). The 39 patients used nicotine replacement therapy, 35 varenicline, 35 varenicline, whereas six patients did not use pharmacotherapy, but six patients did not use pharmacotherapy. During week 12, 35. 5% and 32. 8% respectively at week 26, respectively. Conclusion In conclusion, our findings suggest that smoking cessation is possible in patients with newly diagnosed lung cancer. In addition, pharmacotherapy in lieu of cancer therapy was safe and did not show novel side effects in these critically ill patients. Therefore, smoking cessation should be an integral component of lung cancer treatment.
Source link: https://doi.org/10.1186/s12890-022-02048-1
Background In the United States, eighty percent of the adult homeless population smokes cigarettes compared to 15 percent of the general population. A randomized clinical trial, Power to Quit 2, a randomized clinical trial, was administered in two urban homeless shelters in the Upper Midwest in 2017 to address simultaneous smoking cessation and alcohol therapy among people experiencing homelessness. The Consolidated Framework for Implementation Research outlined the goal of this study was to use participants' experiences with the intervention to inform future implementation attempts of combined smoking cessation and alcohol abstinence interventions. Conclusion With people experiencing homelessness, there are specific difficulties in addressing smoking cessation. Participants described a discordance in their personal goals of lowering compared to the study's goals of complete abstinence, which may pose a challenge to the ways in which homelessness is measured.
Source link: https://doi.org/10.1186/s12889-022-13563-5
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions